Anteris Technologies (Nasdaq: AVR, ASX: AVR) says medtech giant Medtronic (NYSE: MDT) will make a strategic investment of up to $90 million in the transcatheter heart valve developer. The private placement, announced after market close yesterday, requires Medtronic to acquire a 16.0–19.99% stake in Anteris. In addition, Anteris is proposing a … [Read more...] about Medtronic to invest up to $90M in Anteris Technologies
Anteris Technologies
Anteris Technologies launches IPO to support heart valve technology
Anteris Technologies today announced the launch of its initial public offering in the U.S. The company aims to raise funds through the IPO to advance the development of its DurAVR transcatheter heart valve technology. Anteris’ IPO consists of 14.8 million shares of common stock, with an additional 2.22 million shares available to underwriters … [Read more...] about Anteris Technologies launches IPO to support heart valve technology
